Lixte Biotechnology Files 2024 10-K
Ticker: LIXT · Form: 10-K · Filed: Mar 24, 2025 · CIK: 1335105
| Field | Detail |
|---|---|
| Company | Lixte Biotechnology Holdings, INC. (LIXT) |
| Form Type | 10-K |
| Filed Date | Mar 24, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-K, annual-report, biotechnology
TL;DR
Lixte Biotech filed its 2024 10-K. Full financials and ops details inside.
AI Summary
Lixte Biotechnology Holdings, Inc. filed its 2024 10-K on March 24, 2025, reporting on its fiscal year ending December 31, 2024. The company, incorporated in Delaware, operates in the pharmaceutical preparations sector. Key financial data and operational details for the fiscal year 2024 are presented in this filing.
Why It Matters
This filing provides investors with a comprehensive overview of Lixte Biotechnology's financial health and operational performance for the fiscal year 2024, crucial for investment decisions.
Risk Assessment
Risk Level: medium — Biotechnology companies often face high risks due to the nature of drug development and regulatory hurdles, though specific risk factors are not detailed in this summary.
Key Numbers
- 2024-12-31 — Fiscal Year End (Reporting period for the 10-K)
- 2025-03-24 — Filing Date (Date the 10-K was submitted to the SEC)
Key Players & Entities
- LIXTE BIOTECHNOLOGY HOLDINGS, INC. (company) — Filer
- 2024-12-31 (date) — Fiscal Year End
- 2025-03-24 (date) — Filing Date
- DE (location) — State of Incorporation
- 2834 (number) — Standard Industrial Classification (Pharmaceutical Preparations)
FAQ
What is Lixte Biotechnology Holdings, Inc.'s primary business sector?
Lixte Biotechnology Holdings, Inc. operates in the Pharmaceutical Preparations sector, as indicated by its Standard Industrial Classification code 2834.
When did Lixte Biotechnology Holdings, Inc. file its 10-K report?
The company filed its 10-K report on March 24, 2025.
What fiscal year does this 10-K filing cover?
This 10-K filing covers the fiscal year ending December 31, 2024.
In which state was Lixte Biotechnology Holdings, Inc. incorporated?
Lixte Biotechnology Holdings, Inc. was incorporated in Delaware (DE).
What was the company's former name and when did the name change occur?
The company's former name was SRKP 7 INC, and the date of the name change was August 3, 2005.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on March 24, 2025 regarding LIXTE BIOTECHNOLOGY HOLDINGS, INC. (LIXT).